Rhumbline Advisers Clear Point Neuro, Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 37,649 shares of CLPT stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,649Holding current value
$1.03 Million% of portfolio
0.0%Shares
11 transactions
Others Institutions Holding CLPT
# of Institutions
102Shares Held
7.91MCall Options Held
116KPut Options Held
46.8K-
Vanguard Group Inc Valley Forge, PA1.48MShares$40.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA625KShares$17.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$10 Million0.0% of portfolio
-
State Street Corp Boston, MA333KShares$9.11 Million0.0% of portfolio
-
Morgan Stanley New York, NY332KShares$9.08 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $669M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...